Literature DB >> 3494552

Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

C Ferrari, A Penna, P Sansoni, T Giuberti, T M Neri, F V Chisari, F Fiaccadori.   

Abstract

The proliferative response of peripheral blood T cells to hepatitis B surface antigen (HBsAg), pre-S antigen and hepatitis B core antigen (HBcAg) has been studied in 20 patients with hepatitis B virus induced chronic active hepatitis (CAH) and in 12 control subjects. Eleven of the 20 CAH patients showed a significant T lymphocyte proliferative response to HBcAg, whereas no proliferation was detectable in response to envelope antigens (HBs and pre-S) in any patient. T cell subset fractionation revealed that HBcAg specific proliferation was limited to the CD4+ (helper/inducer) population. CD8+ (suppressor/cytotoxic) T cells were unresponsive to HBcAg and did not suppress the proliferative response of autologous CD4+ cells. The HBcAg specific T cell proliferative response did not correlate with serum anti-core antibody titres or with biochemical evidence of liver disease. The present results show the selective presence of HBcAg-sensitized T cells in the peripheral blood of patients with HBsAg positive CAH and suggest that the peripheral lymphoid compartment may not reflect immunopathogenetically important cellular events operative at the site of tissue injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3494552      PMCID: PMC1542471     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers.

Authors:  K R Beutner; M L Tiku; P L Ogra
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  Variable protein composition of hepatitis B surface antigen from different donors.

Authors:  W Stibbe; W H Gerlich
Journal:  Virology       Date:  1982-12       Impact factor: 3.616

4.  Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B.

Authors:  A Trevisan; G Realdi; A Alberti; G Ongaro; E Pornaro; R Meliconi
Journal:  Gastroenterology       Date:  1982-02       Impact factor: 22.682

5.  Inducer and suppressor T-cells in hepatitis B virus-induced liver disease.

Authors:  H C Thomas; D Brown; G Routhier; G Janossy; P C Kung; G Goldstein; S Sherlock
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

6.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.

Authors:  M Mondelli; G M Vergani; A Alberti; D Vergani; B Portmann; A L Eddleston; R Williams
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease.

Authors:  J Aldershvile; O Dietrichson; F Hardt; J O Nielsen; P Skinhöj
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.

Authors:  M L Tiku; K R Beutner; K Tiku; P L Ogra
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

10.  Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.

Authors:  W M Lee; W D Reed; C G Osman; J Vahrman; A J Zuckerman; A L Eddleston; R Williams
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

View more
  15 in total

Review 1.  The cellular immune response to nucleocapsid antigens in hepatitis B virus infection.

Authors:  M U Mondelli; F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1990

Review 2.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

3.  The serology of chronic hepatitis B infection revisited.

Authors:  T Maruyama; A McLachlan; S Iino; K Koike; K Kurokawa; D R Milich
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.

Authors:  Stephan Menne; Carol A Roneker; Michael Roggendorf; John L Gerin; Paul J Cote; Bud C Tennant
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells.

Authors:  Jessica A Chichester; Mark A Feitelson; Catherine E Calkins
Journal:  Immunology       Date:  2006-06-06       Impact factor: 7.397

6.  Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope.

Authors:  S Menne; J Maschke; T K Tolle; M Lu; M Roggendorf
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Autopresentation of hepatitis B virus envelope antigens by T cells.

Authors:  C Ferrari; M Pilli; A Penna; A Bertoletti; A Valli; A Cavalli; G Pasetti; F Fiaccadori
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 8.  Hepatitis B virus immunopathology.

Authors:  F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1995

9.  Immune response to hepatitis B virus surface antigen peptides during HBV infection.

Authors:  A Mishra; H Durgapal; V Manivel; S K Acharya; K V Rao; S K Panda
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens.

Authors:  A Penna; P Fowler; A Bertoletti; S Guilhot; B Moss; R F Margolskee; A Cavalli; A Valli; F Fiaccadori; F V Chisari
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.